AMGEN PRESENTS NEW TARLATAMAB CLINICAL DATA AT WCLC 2022 apnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from apnews.com Daily Mail and Mail on Sunday newspapers.
AMGEN PRESENTS NEW TARLATAMAB CLINICAL DATA AT WCLC 2022 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ Amgen (NASDAQ: AMGN) today announced three new data sets from its thoracic oncology portfolio that will be presented at the International.
/PRNewswire/ Amgen (NASDAQ:AMGN) today announced financial results for the second quarter of 2022. Key results include: Total revenues increased 1% to $6.6.
/PRNewswire/ Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $1.94 per share dividend for the third quarter of 2022. The dividend.